Goldhaber SZ - Search Results

1

Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.

Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B, Huang W, Anderson FA Jr; ENDORSE Investigators. Kakkar AK, et al. Among authors: goldhaber sz. Ann Surg. 2010 Feb;251(2):330-8. doi: 10.1097/SLA.0b013e3181c0e58f. Ann Surg. 2010. PMID: 20054273

2

A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.

Goldhaber SZ, Tapson VF; DVT FREE Steering Committee. Goldhaber SZ, et al. Am J Cardiol. 2004 Jan 15;93(2):259-62. doi: 10.1016/j.amjcard.2003.09.057. Am J Cardiol. 2004. PMID: 14715365

3

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.

Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Leizorovicz A, et al. Among authors: goldhaber sz. Circulation. 2004 Aug 17;110(7):874-9. doi: 10.1161/01.CIR.0000138928.83266.24. Epub 2004 Aug 2. Circulation. 2004. PMID: 15289368 Clinical Trial.

4

Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.

Joffe HV, Kucher N, Tapson VF, Goldhaber SZ; Deep Vein Thrombosis (DVT) FREE Steering Committee. Joffe HV, et al. Among authors: goldhaber sz. Circulation. 2004 Sep 21;110(12):1605-11. doi: 10.1161/01.CIR.0000142289.94369.D7. Epub 2004 Sep 7. Circulation. 2004. PMID: 15353493 Free article.

5

Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.

Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ; PREVENT Medical Thromboprophylaxis Study Group. Vaitkus PT, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Jan;93(1):76-9. doi: 10.1160/TH04-05-0323. Thromb Haemost. 2005. PMID: 15630494

6

Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.

Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Kucher N, et al. Among authors: goldhaber sz. Arch Intern Med. 2005 Feb 14;165(3):341-5. doi: 10.1001/archinte.165.3.341. Arch Intern Med. 2005. PMID: 15710801

7

Gender differences in the administration of prophylaxis to prevent deep venous thrombosis.

Kucher N, Tapson VF, Quiroz R, Mir SS, Morrison RB, McKenzie D, Goldhaber SZ; DVT FREE Steering Committee. Kucher N, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Feb;93(2):284-8. doi: 10.1160/TH04-08-0513. Thromb Haemost. 2005. PMID: 15711744

8

Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients.

Kucher N, Tapson VF, Goldhaber SZ; DVT FREE Steering Committee. Kucher N, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Mar;93(3):494-8. doi: 10.1160/TH04-09-0587. Thromb Haemost. 2005. PMID: 15735800

9

High utilization rate of vena cava filters in deep vein thrombosis.

Jaff MR, Goldhaber SZ, Tapson VF. Jaff MR, et al. Among authors: goldhaber sz. Thromb Haemost. 2005 Jun;93(6):1117-9. doi: 10.1160/TH04-10-0645. Thromb Haemost. 2005. PMID: 15968397

10

Thrombosis during pregnancy and the postpartum period.

James AH, Tapson VF, Goldhaber SZ. James AH, et al. Among authors: goldhaber sz. Am J Obstet Gynecol. 2005 Jul;193(1):216-9. doi: 10.1016/j.ajog.2004.11.037. Am J Obstet Gynecol. 2005. PMID: 16021082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters